D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.